We are live on
!
Find out more
GCM
Gladius Capital Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
25.75%
This Fund
S&P 500
This Quarter
Est. Return
-17.23%
1 Year Est. Return
+25.75%
3 Year Est. Return
+78.03%
5 Year Est. Return
+67.88%
10 Year Est. Return
+218.88%
AUM
$1.93B
AUM Growth
+$574M
(+42%)
Cap. Flow
+$864M
Cap. Flow
% of AUM
44.87%
Top 10 Holdings %
Top 10 Hldgs %
51.25%
Holding
447
New
182
Increased
81
Reduced
82
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$29.2M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$27.6M |
| 4 |
Netflix
NFLX
|
+$21.2M |
| 5 |
Caterpillar
CAT
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$40M |
| 2 |
Gilead Sciences
GILD
|
+$18.9M |
| 3 |
Tesla
TSLA
|
+$8.3M |
| 4 |
Wells Fargo
WFC
|
+$5.87M |
| 5 |
Visa
V
|
+$3.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.14% |
| 2 | Industrials | 2.22% |
| 3 | Communication Services | 1.34% |
| 4 | Financials | 1.2% |
| 5 | Consumer Staples | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
United Therapeutics
UTHR
$21.9B
| $71K | ﹤0.01% |
+301
| New | +$61.2K |
|
227
Amgen
AMGN
$204B
| $68K | ﹤0.01% |
277
+42
| +18% | +$10.3K |
|
228
Northwest Natural Holdings
NWN
$2.06B
| $68K | ﹤0.01% |
+1,273
| New | +$65.7K |
|
229
Phibro Animal Health
PAHC
$1.51B
| $68K | ﹤0.01% |
+3,553
| New | +$67.3K |
|
230
SunCoke Energy
SXC
$714M
| $67K | ﹤0.01% |
+9,731
| New | +$78.5K |
|
231
Tredegar Corp
TG
$267M
| $66K | ﹤0.01% |
+6,502
| New | +$75.4K |
|
232
Verizon
VZ
$197B
| $64K | ﹤0.01% |
1,251
-2,846
| -69% | -$144K |
|
233
Winmark
WINA
$1.25B
| $64K | ﹤0.01% |
+325
| New | +$66.6K |
|
|
BIG
234
DELISTED
Big Lots, Inc.
BIG
| $64K | ﹤0.01% |
3,051
+689
| +29% | +$20.3K |
|
235
Bassett Furniture
BSET
$169M
| $61K | ﹤0.01% |
+3,337
| New | +$55.3K |
|
|
VOXX
236
DELISTED
VOXX International Corporation Class A
VOXX
| $61K | ﹤0.01% |
+6,447
| New | +$53K |
|
|
CCRN
237
DELISTED
Cross Country Healthcare
CCRN
| $60K | ﹤0.01% |
+2,857
| New | +$53.5K |
|
238
Valhi
VHI
$380M
| $60K | ﹤0.01% |
+1,322
| New | +$52.6K |
|
239
V2X
VVX
$2.7B
| $60K | ﹤0.01% |
+1,767
| New | +$62.5K |
|
240
Orrstown Financial Services
ORRF
$859M
| $58K | ﹤0.01% |
+2,379
| New | +$56.9K |
|
|
ACH
241
Accendra Health
ACH
$261M
| $57K | ﹤0.01% |
+1,791
| New | +$64.9K |
|
242
Park-Ohio Holdings
PKOH
$581M
| $57K | ﹤0.01% |
+3,569
| New | +$50.2K |
|
243
Financial Institutions
FISI
$838M
| $56K | ﹤0.01% |
+2,122
| New | +$59K |
|
|
STON
244
DELISTED
StoneMor Inc.
STON
| $56K | ﹤0.01% |
+16,183
| New | +$46K |
|
245
Ironwood Pharmaceuticals
IRWD
$728M
| $55K | ﹤0.01% |
+4,761
| New | +$56.1K |
|
246
Lincoln Electric
LECO
$14.6B
| $54K | ﹤0.01% |
434
-603
| -58% | -$79.4K |
|
247
Scholastic
SCHL
$794M
| $54K | ﹤0.01% |
+1,475
| New | +$54.5K |
|
|
TRST
248
Trustco Bank Corp NY
TRST
$975M
| $54K | ﹤0.01% |
+1,734
| New | +$54.1K |
|
249
Global Industrial
GIC
$1.39B
| $53K | ﹤0.01% |
+1,544
| New | +$50.5K |
|
250
Myers Industries
MYE
$1.38B
| $53K | ﹤0.01% |
+2,312
| New | +$52.4K |
|
Similar funds
ACM
CCM
BFPW
PP
RIA
GACM
GA
Gladius Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Gladius Capital Management held 447 positions worth $1.93B, up 42% from $1.35B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Gladius Capital Management deployed $864M of net new capital in Q2 2022, opening 182 new positions and adding to 81 existing holdings. Its largest new stake was Apple: 122,194 shares worth $16.7M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 1.3% a quarter earlier, followed by Industrials and Communication Services.
On the sell side, the largest reduction was Gilead Sciences, an estimated $18.9M trimmed.
- Gladius Capital Management's largest Q2 2022 buy was Apple: 122,194 shares worth $16.7M.
- Gladius Capital Management added most to iShares MSCI EAFE ETF in Q2 2022, an estimated $109M increase.
- Gladius Capital Management's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $18.9M.
- Gladius Capital Management fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $40M.
- Gladius Capital Management's ten largest holdings make up 51% of its $1.93B portfolio in Q2 2022.
- Gladius Capital Management opened 182 new positions and closed 99 in Q2 2022.
- Gladius Capital Management's portfolio value rose 42% quarter-over-quarter to $1.93B.
Based on Gladius Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.